Description:
Dr Todd Levine, with 20 years of experience as a clinical neurologist with specialty in disorders of the peripheral nervous system, shares with us about the Syn-One skin biopsy run by his company, CND Life Sciences.
Against a backdrop of clinical information about the divisions of the nervous system (central vs peripheral and sensory vs motor vs autonomic), we review the 3 tests in this procedure: small fiber nerve counts, synuclein and amyloid deposition.
Dr Levine notes that brain & skin both come from ectoderm tissue in the embryo, meaning they arise from similar roots soon after conception The skin, unlike the brain, is readily available for testing, and can offer insight to what’s potentially happening in the central nervous system without having to go there directly.
It’s also a fascinating conversation that one-half to one-third of all neuropathies end up classified as ‘idiopathic’,
meaning we can’t identify a trigger, like toxic chemical insult or injury. Most likely, these neurons are injured by ‘an accumulation of small insults” which can include low but recurrent or persistent viral illnesses and environmental chemical exposure all further complicated with and by metabolic syndromes. His most exciting area of research is looking at the potential of this test to give
predictive insights for diseases decades in the making (like Parkinson’s or Lewy Body Dementia), all work that we agree with & support at Neuroveda Health when we apply personalized medicine plans for your best health.

BIO:
Dr. Todd Levine has over 20 years of experience as a
clinical neurologist with a sub-specialty in disorders of the peripheral nervous system. He received his medical degree from Duke University and did his residency and fellowship at Washington University in St Louis. He has served as Chairman of the Neuromuscular Division of the American Academy of Neurology. In 2010, he founded his first medical diagnostics company called Corinthian
Reference Lab (CRL), and has processed over 50,000 skin biopsies, receiving specimens from over 4,000 different neurologists across the US and Canada. Dr Levine is one of the three founders of CND Life Sciences and serves as its Chief Medical Officer, playing a key role in the delivery of diagnostic services and ongoing technology development. Dr. Levine also serves currently as the Director of Neuroscience Research at the Honor Health Research Institute in Phoenix, AZ.